Suzhou Zelgen Biopharmaceuticals
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (67)
Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung Cancer
Started: 12/12/2025
A Phase III Study of Jaktinib in Adults With Moderate and Severe Atopic Dermatitis
Started: 7/14/2022
Efficacy and Safety Study of Jaktinib in Subjects With Active Ankylosing Spondylitis(AS)
Started: 7/20/2023
Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata
Started: 3/25/2022
Study to Evaluate the Safety and Efficacy of Jaktinib in Adults With Alopecia Areata
Started: 9/4/2021
Comparison of the Efficacy and Safety of rhTSH as An Adjunctive Diagnostic Tool in Differentiated Thyroid Cancer Patients Who Had Been Thyroidectomized Vs. Patients Who After Thyroid Hormone Withdrawal
Started: 9/10/2021
Jaktinib Versus Hydroxycarbamide in Subjects With Intermediate-2 or High-risk Myelofibrosis
Started: 2/5/2021
Safety and Efficacy of Topical Recombinant Human Thrombin(rhThrombin) for Surgical Hemostasis
Started: 11/11/2019
Donafenib for Previously Treated Metastatic Colorectal Cancer
Started: 12/28/2016
A Phase 3 Study of Donafenib in Patients With Radioiodine-refractory Differentiated Thyroid Cancer
Started: 8/29/2018
A Study of ZG006 for Injection Versus Investigator-Selected Chemotherapy in Participants With Advanced Neuroendocrine Carcinoma
Started: 7/1/2026
Study of ZG005 in Combination With Platinum-Based Chemotherapy in Participants With Advanced Biliary Tract Carcinoma
Started: 12/2/2025
Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular Carcinoma
Started: 10/24/2024
Study of ZG005 in Patients With Advanced Solid Tumors
Started: 6/13/2025
Study of ZG006 in Participants With Neuroendocrine Prostate Cancer
Started: 8/1/2025
A Phase 2 Study of Jaktinib in Participants With Moderate to Severe Psoriasis
Started: 3/11/2021
Study of Jaktinib Hydrochloride Tablets in Participants With Idiopathic Pulmonary Fibrosis
Started: 9/8/2020
Alkotinib Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib
Started: 1/21/2020
Efficacy and Safety of Jaktinib in Participants With Severe Novel Coronavirus Pneumonia(COVID-19)
Started: 9/1/2022
Study of Jaktinib In Patients With Myelofibrosis Who Were Relapsed or Refractory of Ruxolitinib Treatment.
Started: 7/28/2021
Jaktinib for the Treatment of Ruxolitinib Intolerance of Myelofibrosis
Started: 1/7/2020
Jaktinib Hydrochloride Tablets In The Treatment of Active Ankylosing Spondylitis
Started: 12/1/2020
Clinical Study of Jaktinib in the Treatment of Patients With Moderate and Severe Atopic Dermatitis
Started: 12/2/2020
Study to Evaluate the Safety and Efficacy ofJaktinib Hydrochloride Tablets in Severe Alopecia Areata
Started: 11/18/2019
Jaktinib Hydrochloride Tablets in Intermediate-risk and High-risk Myelofibrosis.
Started: 1/8/2019
Efficacy and Safety of Donafenib in Patients With Advanced Hepatocellular Carcinoma
Started: 3/1/2016
Phase 2 Trial of Donafenib in 131I-Refractory Differentiated Thyroid Cancer
Started: 9/1/2016
Study of ZG006 in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors as First-Line Standard Therapy in Participants With Extensive Stage Small-Cell Lung Cancer
Started: 4/21/2026
Study of ZGGS34 in Participants With Advanced Solid Tumors
Started: 12/31/2025
Study of ZG005 Combined With Gecacitinib in Patients With Advanced Non-Small Cell Lung Cancer
Started: 5/23/2025
Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma
Started: 5/16/2025
Study of ZGGS18 in Patients With Advanced Solid Tumors
Started: 11/15/2022
ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
Started: 9/23/2025
Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
Started: 10/27/2023
Study of ZG005 in Combination With Gecacitinib in Participants With Advanced Cervical Cancer
Started: 9/23/2025
Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid Tumors
Started: 5/20/2025
Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer
Started: 9/2/2024
A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer
Started: 3/31/2025
Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Neuroendocrine Carcinoma.
Started: 8/29/2024
A Study of ZG005 Combined With Donafenib in Patients With Advanced Solid Tumor
Started: 5/10/2024
Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma.
Started: 5/30/2024
A Study of ZG005 in Patients With Advanced Solid Tumors
Started: 6/17/2022
Study of ZG005 in Combination With Paclitaxel＋Platinum-based ± Bevacizumab in Patients With Advanced Cervical Carcinoma
Started: 3/27/2024
Study of ZG0895.HCl in Patients With Advanced Solid Tumors
Started: 8/8/2023
A Pharmacokinetic Study of Gecacitinib Hydrochloride Tablets in Healthy Adult Participants.
Started: 5/12/2026
A Phase 1/2 Study of Donafenib in Combination With KN046 in Advanced Gastrointestinal Tumors
Started: 1/19/2021
Study of ZGGS15 in Patients With Advanced Solid Tumors
Started: 7/19/2023
Study of ZG005 in Combination With Gecacitinib and Chemotherapy for Participants With Advanced Solid Tumors
Started: 9/1/2025
A Study to Evaluate the Effect of Jaktinib on QT/QTc Interval in Healthy Participants
Started: 3/19/2024
Jaktinib Hydrochloride Cream For Atopic Dermatitis
Started: 10/14/2020
Study of Alkotinib in Patients With Advanced Non Small Cell Lung Cancer
Started: 10/18/2018
Clinical Trial of Dose-tolerance, Pharmacokinetics and Iodine Uptake For rhTSH In Post-thyroidectomized Patients
Started: 6/10/2019
A Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics of Jaktinib in Healthy Volunteers
Started: 10/27/2021
Comparative Study on Pharmacokinetics of Two Formulations of Jaktinib in Healthy Adults Under Fasting Conditions
Started: 11/29/2023
ADME Study of [14C]-Jaktinib in Healthy Male Subjects
Started: 1/4/2022
Pharmacokinetics Of Jaktinib In Subjects With Hepatic Impairment And Normal Hepatic Function
Started: 8/27/2021
A Study of Donafenib Monotherapy in Advanced Oesophageal Cancer
Started: 7/21/2015
Donafenib Monotherapy for Previously Treated Metastatic Gastric Cancer
Started: 5/16/2016
Donafenib Monotherapy for Previously Treated Metastatic Nasopharyngeal Carcinoma
Started: 2/8/2017
Jaktinib and Azacitidine In Treating Patients With MDS With MF or MDS/MPN With MF.
Started: 9/30/2021
Combination of Donafenib and Cytarabine/Daunorubicin in Relapsed AML
Started: 11/6/2018
Topical rhThrombin as an Adjunct to Hemostasis During Segmental Hepatectomy
Started: 11/29/2017
To Evaluate the Effect of Food on the Pharmacokinetic Characteristics of Alkotinib Capsules in Healthy Subjects
Started: 11/20/2019
The Mass Balance and Biotransformation of [14C]Donafenib in Healthy Adult Man
Started: 10/9/2018
Safety and Efficacy of Donafenib in Patients With Advanced Hepatocellular Carcinoma
Started: 4/1/2014
The Tolerance, Pharmacokinetics of Jaktinib in Healthy Volunteers
Started: 9/28/2017
Donafenib Monotherapy for Previously Treated Metastatic Colorectal Cancer
Started: 3/1/2014